May 8, 2025
The clinical trial of the LIVERATION project, funded by Horizon Europe, has reached 110 randomized patients.
Each of these individuals has agreed to take part in this international study, which aims to advance liver cancer treatment. Patients are randomly assigned to two groups: one follows the current standard of care after liver surgery, while the other receives an additional radiofrequency ablation on the tumor margins. The goal is to assess whether this technique may provide benefits in terms of local recurrence and long-term outcomes for patients.
With active centres in Spain, Italy, Switzerland, and Slovenia, LIVERATION continues to move forward thanks to the involvement and coordination of all project partners and collaborators.
Thank you to everyone making this possible. We keep moving forward.